The DEFA14A filing lacks any material disclosure about the subject of the proxy solicitation. Monitor for a definitive proxy statement or additional soliciting materials that may clarify the purpose of the vote.
OCGN drugs
OCGN drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $0.9721entry
- T+1 · 7d ago −2.27%α −1.91% · $0.9500
- T+5 · 20h ago −20.48%α −18.79% · $0.7730
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Ocugen, Inc. filed a DEFA14A (additional definitive proxy soliciting materials) on November 6, 2026. The filing contains no substantive proxy content beyond the form type and metadata; the document text is limited to boilerplate SEC form headers and graphic images. No specific shareholder vote, activist campaign, or merger proposal is described.
Key Facts
- Form DEFA14A filed by Ocugen, Inc. on 2026-11-06
- Filed by the registrant (management)
- No substantive proxy content in the filing text
- Market cap $297M, normal daily move 4.9%
Financial Impact
No financial figures disclosed in the filing
Risk Factors
- Filing contains no substantive information about the proxy matter
- Document content limited to boilerplate and graphic images
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001140361-26-042516 |
| Document: 0001140361-26-042516-index-headers.html | 0001140361-26-042516 |
| Document: 0001140361-26-042516-index.html | 0001140361-26-042516 |
| Document: 0001140361-26-042516.txt | 0001140361-26-042516 |
Track record
23 reports on OCGN
3 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +20.49% at T+20 after the Jun 11, 2026 report. 4 of 6 went positive at some point.
Filters
- Nov 10, 20266d ago 8-K Neutral 4/10 Entry $0.9500 to $0.9604 Now $0.7730 −18.63% ▲ +1.09% −0.22% vs SPY
- Nov 10, 20266d ago Press Release Neutral 4/10 Entry $0.9500 to $0.9604 Now $0.7730 −18.63% ▲ +1.09% −0.22% vs SPY
- Nov 6, 202610d ago DEFA14A Neutral 2/10 Viewing Entry $0.9721 to $0.9500 Now $0.7730 −20.48% ▼ −2.27% −1.91% vs SPY
- Nov 6, 202610d ago DEFA14A Neutral 3/10 Entry $0.9721 to $0.9500 Now $0.7730 −20.48% ▼ −2.27% −1.91% vs SPY
- Nov 4, 202612d ago 8-K Neutral 4/10 No price data
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $0.8745 to $0.8165 Now $0.7730 −11.61% ▼ −6.63% −2.22% vs SPY
- Oct 15, 20264w ago 8-K Neutral 5/10 Entry $0.8137 to $0.7803 Now $0.7730 −5.00% ▼ −4.10% −3.00% vs SPY
- Oct 14, 20264w ago 8-K Mixed 5/10 Entry $0.8137 to $0.7803 Now $0.7730 −5.00% ▼ −4.10% −3.00% vs SPY
- Oct 9, 20265w ago 144 Neutral 2/10 Entry $0.9472 to $0.8854 Now $0.7730 −18.39% ▼ −6.52% −6.51% vs SPY
- Sep 1, 202610w ago Press Release Bullish 7/10 Entry $1.33 to $1.32 Now $0.7730 −41.88% ▼ −0.75% −1.20% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers